IRCT20230222057495N18招募中Unknown
Bioequivalence study of dapagliflozin 10 mg tablet of Viana Darou Sanat pharmaceutical company compared to dapagliflozin 10 mg sample of AstraZeneca company in Australia on healthy volunteers
Viana Darou Sanat Pharmaceutical company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Healthy volunteer between 18 and 55 years old.
- •Body mass index less than 30 kg per square meter.
- •All candidates must be non-smokers.
排除标准
- •Blood pressure less than 90 on 60 mm Hg or more than 140 on 90 mm Hg.
- •Consumption of any drug, alcohol or tobacco within 2 weeks before receiving the drug.
研究者
相似试验
招募中
Unknown
Bioequivalence study of Dapagliflozin 10 mgIRCT20200623047902N37Actover Co.24
招募中
Unknown
Bioequivalence study of empagliflozin 10 mg tabletIn the present study, no disease was investigated..IRCT20230222057495N3Yab Daro Company24
已完成
不适用
Bioequivalence Study of Dapagliflozin 10 mg Film-coated TabletsHealthyNCT06127212Dexa Medica Group24
已完成
1 期
Bioequivalence of Dapagliflozin 10 mg Tablets Under Fed ConditionsHealthy SubjectsNCT04881006Jiangsu Hansoh Pharmaceutical Co., Ltd.30
已完成
1 期
Bioequivalence of Dapagliflozin 10 mg Tablets Under Fasting ConditionsHealthy SubjectsNCT04880993Jiangsu Hansoh Pharmaceutical Co., Ltd.30